We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
THYMOPENTIN
Molecular Formula
C30H49N9O9
Molecular Weight
268.93
CAS No.
69558-55-0
Quality Standard
99% up, medical grade
Appearance
White powder
Sequence
Arg-Lys-Asp-Val-Tyr-NH2
Character
Composed of arginine, lysine, aspartic acid, tyrosine and valine amino acid
COA of Thymopentin
Test Item
Specification
Results
Appearance
White to off-white powder
Off-white powder
Solubility
Very soluble in water, slightly soluble in ethanol, insoluble in ethyl acetate, ether and petroleum ether
Conform
Specific rotation
-14.0o ~ -22.0o
-16.5o
Biuret reaction
Should appear positive reaction
Positive reaction
IR
Infrared spectrogram should conform to reference substance
Conform
HPLC
Retention time of main peak of test sample should be consistent with reference substance
Conform
pH
7.0-9.0
8.1
Water
NMT 5.0%
2.6%
Amino acids
Arg 0.8-1.2
Asp 0.8-1.2
Lys 0.8-1.2
Tyr 0.8-1.2
Val 0.8-1.2
Conform
Related substance
Single impurity NMT 1.5%
Total impurity NMT 2.5%
0.2%
0.3%
Bacterial endotoxin
< 5EU/mg
Conform
Assay
97.0% - 103.0%
101.1%
Conclusion
It conforms to the enterprise standard
Usage
Introduction of Thymopentin 69558-55-0:
Pharmacological effects: Cell immunoregulatory drugs, can induce T cell differentiation and promote the development of T lymphocyte subsets, mature and activation function, and to adjust the proportion of lymphocyte subsets, it close to normal.
Indications:
Can be used to improve the radiotherapy and chemotherapy for cancer patients immunocompromised result. It can normalize and prevent all kinds of cellular immune deficiency to some extent and thus a potential immune modulating agents.
Twenty years of qualification
Audited Supplier
Pharma Sources Insight JANUARY 2024
